LUNG Q4 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+12.5% YoY

Gross Profit

$11M72.5% margin

Operating Income

-$15M-94.8% margin

Net Income

-$14M-92.6% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+14.2%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$194M

Total Liabilities

$40M

Stockholders' Equity

$154M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$14M	+12.5%
Gross Profit	$11M	$10M	+9.1%
Operating Income	-$15M	-$12M	-18.3%
Net Income	-$14M	-$13M	-9.8%

Geographic Segments

UNITED STATES

$9M61%

EMEA

$5M33%

Asia Pacific

$786,0005%

Other International Geographical Areas

$57,0000%